BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Supernus Pharmaceuticals Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer

  July 20, 2012

   · 

  1 min read
• Business

  Gilead Sciences, Inc. to Release Second Quarter 2012 Financial Results on Thursday, July 26, 2012

  July 20, 2012

   · 

  1 min read
• Business

  Somaxon Pharmaceuticals, Inc. to Raise $3.0 Million in Registered Direct Offering

  July 20, 2012

   · 

  1 min read
• Business

  Dyax Corp. Announces Second Quarter 2012 Financial Results

  July 20, 2012

   · 

  1 min read
• Business

  Quest Diagnostics Inc. Reports Second Quarter 2012 Financial Results

  July 20, 2012

   · 

  6 min read
• BioMidwest

  PDL BioPharma, Inc. to Announce Second Quarter 2012 Financial Results on August 2, 2012

  July 20, 2012

   · 

  1 min read
• Lone Star Bio

  Vermillion Sets Second Quarter 2012 Conference Call for Tuesday, August 14, 2012 at 4:30 p.m. ET

  July 20, 2012

   · 

  1 min read
• Drug Development

  Bionor Pharma ASA’s Therapeutic HIV Vaccine Vacc-4x Improves Quality of Immune Responses in HIV Patients, Resulting in Long-Term Reduction in Viral Load and Potential for Periodic “Boosts” That Could Result in New Treatment Option for People Living With H

  July 20, 2012

   · 

  6 min read
• Primcogent Solutions Launches Lunula Laser

  July 20, 2012

   · 

  3 min read
• Pharm Country

  BrainStorm Cell Therapeutics Inc. Closes $5.7 Million Public Offering

  July 20, 2012

   · 

  1 min read